Psychedelic Medicine
Featured Article
How Mindbloom’s CEO sees the future of psychedelic mental health
“What was something amazing that happened to you this weekend,” Mindbloom’s CEO Dylan Beynon asked me, less than 30 seconds into our call. His bright eyes and relaxed demeanor radiated a deep peace and presence, paired with what seemed like a genuine care for the other person on the call — something that’s rare in…
6:00 am PDT • March 27, 2023
Biotech & Health
Synthesis Institute collapse is a major setback for US psychedelic therapy
7:00 am PDT • March 12, 2023
The ramifications of Synthesis Center’s collapse could have a destabilizing impact on the nascent commercial psychedelics community as a whole.
Startups
Fireside Project manifests a $200K fund to improve access to careers in psychedelic health
9:30 am PST • March 2, 2022
Let’s get three truths out of the way. 1. Drugs are a sensitive topic. 2. In a lot of the world, many drugs that can be used recreationally — including…
